2020. Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s46. DOI:https://doi.org/10.25251/skin.4.supp.46.